Peeling skin syndrome type A
ORPHA:263548Activated PI3K-delta syndrome 1
ORPHA:693661Activated PI3K-delta syndrome 2
ORPHA:693681Alexander disease type I
ORPHA:363717Alexander disease type II
ORPHA:363722Autoimmune hepatitis type 1
ORPHA:563576Autoimmune hepatitis type 2
ORPHA:563581Autoimmune pancreatitis type 1
ORPHA:280302Autoimmune pancreatitis type 2
ORPHA:280315Autoimmune polyendocrinopathy type 1
ORPHA:3453Autoimmune polyendocrinopathy type 2
ORPHA:3143Autoimmune polyendocrinopathy type 3
ORPHA:227982Autoimmune polyendocrinopathy type 4
ORPHA:227990Autosomal recessive intermediate Charcot-Marie-Tooth disease type A
ORPHA:217055Dihydropteridine reductase deficiency
ORPHA:226Lafora disease
ORPHA:501Peeling skin syndrome
ORPHA:817Peeling skin syndrome type B
ORPHA:263553Progressive myoclonic epilepsy type 3
ORPHA:263516Progressive myoclonic epilepsy type 5
ORPHA:402082Progressive myoclonic epilepsy type 6
ORPHA:280620Progressive myoclonic epilepsy type 7
ORPHA:435438Progressive myoclonic epilepsy type 8
ORPHA:424027Progressive myoclonic epilepsy type 9
ORPHA:457265Pseudohypoaldosteronism type 1
ORPHA:756Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A
ORPHA:308386Thymoma type A
ORPHA:263310